Is Novavax Stock a Buy After Nearly Tripling on the $1.3 Billion Sanofi Deal?
Novavax (NVAX) stock nearly tripled in two days in May after signing a licensing deal worth about $1.3 billion with …
Novavax (NVAX) stock nearly tripled in two days in May after signing a licensing deal worth about $1.3 billion with …
Shares of Apple, Microsoft, Google parent company Alphabet, Amazon, Nvidia, Meta Platforms and Tesla, also known as the “Magnificent Seven,” …
Pfizer (PFE) stock is trading near an 11-year low as the drugmaker hopes for its next big breakthrough after developing …
Stock of artificial intelligence chips Arm stocks (ARM) rose as much as 152% past the recent buy point. With this …
There is a lot for bulls and bears to discuss Palantir Technologies (PLTR). Bulls point to improving profitability for PLTR …